W. Kiger

发表

Boron Neutron Capture Therapy: Cellular Targeting of High Linear Energy Transfer Radiation

O. Harling, J. Coderre, K. Riley, 2003, Technology in cancer research & treatment.

Ablative radiotherapy improves survival in autochthonous cancer mouse models

M. V. Vander Heiden, M. Hurwitz, K. Wittrup, 2022, bioRxiv.

BNCT MICRODOSIMETRY OF A RAT GLIOMA MODEL WITH BPA-F OR BSH

H. Patel, R. Zamenhof, W. Kiger, 2001 .

Pharamacokinetic Modeling for Boronophenylalanine-fructose Mediated Neutron Capture Therapy: 10B Concentration Predictions and Dosimetric Consequences

M. Palmer, P. Busse, K. Riley, 2004, Journal of Neuro-Oncology.

Progress with the NCT international dosimetry exchange.

M. Marek, I. Auterinen, P. Binns, 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Tolerance of normal human brain to boron neutron capture therapy.

J. Hopewell, O. Harling, J. Coderre, 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

Shinji Kawabata, Teruhito Aihara, Otto K Harling, 2012, Radiation oncology.

Pharamacokinetic modeling for boronophenylalanine-fructose mediated neutron capture therapy:10B concentration predictions and dosimetric consequences

M. Palmer, P. Busse, K. Riley, 2003, Journal of Neuro-Oncology.

A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease

I. Kaplan, M. Palmer, C. Chuang, 2003, Journal of Neuro-Oncology.

Preliminary treatment planning and dosimetry for a clinical trial of neutron capture therapy using a fission converter epithermal neutron beam.

I. Kaplan, M. Palmer, P. Busse, 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Treatment planning and dosimetry for the Harvard-MIT Phase I clinical trial of cranial neutron capture therapy.

J. T. Goorley, M. Palmer, P. Busse, 2002, International journal of radiation oncology, biology, physics.

The Harvard-MIT BNCT Program

I. Kaplan, M. Palmer, C. Chuang, 2001 .

Reference dosimetry calculations for neutron capture therapy with comparison of analytical and voxel models.

W S Kiger, J. T. Goorley, J T Goorley, 2002, Medical physics.

An international dosimetry exchange for boron neutron capture therapy, Part I: Absorbed dose measurements.

J. Capala, L. Viererbl, P. Munck Af Rosenschöld, 2005, Medical Physics (Lancaster).

Improved dose targeting for a clinical epithermal neutron capture beam using optional (6)Li filtration.

O. Harling, K. Riley, P. Binns, 2007, International journal of radiation oncology, biology, physics.

A Critical Examination of the Results from the Harvard-MIT NCT Program Phase I Clinical Trial of Neutron Capture Therapy for Intracranial Disease

I. Kaplan, M. Palmer, C. Chuang, 2004, Journal of Neuro-Oncology.

A Pharmacokinetic Model for the Concentration of Boron-10 in Blood Following Boronophenylalanine-Fructose Administration in Humans

M. Palmer, P. Busse, R. Zamenhof, 2001 .

An international dosimetry exchange for BNCT part II: computational dosimetry normalizations.

S. Savolainen, L. Viererbl, T. Seppälä, 2008, Medical physics.

Unifying dose specification between clinical BNCT centers in the Americas.

O. Harling, S. González, K. Riley, 2008, Medical physics.

Effects of boron neutron capture irradiation on the normal lung of rats.

J. Hopewell, O. Harling, J. Coderre, 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Normalisation of prescribed dose in BNCT.

O. Harling, K. Riley, P. Binns, 2007, Radiation protection dosimetry.

Functional and Histological Changes in Rat Lung after Boron Neutron Capture Therapy

J. Hopewell, P. Busse, O. Harling, 2008, Radiation research.

Bicalutamide alone prior to brachytherapy achieves cytoreduction that is similar to luteinizing hormone-releasing hormone analogues with less patient-reported morbidity.

I. Kaplan, J. Petit, S. Berg, 2008, Urologic oncology.

A Comparison of Two BNCT Treatment Planning Programs

Jacek Capala, T. Goorley, F. Wheeler, 2001 .

Boron microquantification in oral muscosa and skin following administration of a neutron capture therapy agent.

J. Coderre, P. Micca, G. Morris, 2002, Radiation Protection Dosimetry.

Application of a Novel Microdosimetry Analysis and its Radiobiological Implication for High-LET Radiation

Xing-Qi Lu, W. Kiger, 2009, Radiation research.

Microdosimetric analysis for high LET radiation.

W. Kiger, X.-Q. Lu, 2006, Radiation protection dosimetry.

Ablative radiotherapy improves survival but does not cure autochthonous mouse models of prostate and colorectal cancer

M. V. Vander Heiden, M. Stevenson, E. Holupka, 2023, Communications medicine.

Development and application of an unconstrained technique for patient positioning in fixed radiation beams.

W S Kiger, J R Albritton, X Q Lu, 2004, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Current status of boron neutron capture therapy of high grade gliomas and recurrent head and neck cancer

I. Kato, Minoru Suzuki, R. Barth, 2012, Radiation Oncology.

Androgen deprivation-mediated cytoreduction before interstitial brachytherapy for prostate cancer does not abrogate the elevated risk of urinary morbidity associated with larger initial prostate volume.

I. Kaplan, J. Petit, S. Berg, 2007, Brachytherapy.